Precipio, Inc. (NASDAQ:PRPO – Get Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $6.14 and traded as low as $4.96. Precipio shares last traded at $5.19, with a volume of 1,954 shares trading hands.
Precipio Stock Up 4.4 %
The company’s 50 day moving average price is $5.76 and its 200 day moving average price is $6.14. The company has a quick ratio of 0.62, a current ratio of 0.78 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $7.63 million, a price-to-earnings ratio of -1.52 and a beta of 1.27.
Precipio (NASDAQ:PRPO – Get Free Report) last issued its earnings results on Tuesday, May 14th. The biotechnology company reported ($1.46) earnings per share (EPS) for the quarter. Precipio had a negative return on equity of 46.12% and a negative net margin of 31.00%. The business had revenue of $3.43 million for the quarter.
About Precipio
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
See Also
- Five stocks we like better than Precipio
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Earnings Per Share Calculator: How to Calculate EPS
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
